Skip to main content

2020 and 2021 PdCCRS Funding Round Updates


Cancer Australia and its Funding Partners would like to congratulate the successful Ideas Grant applicants to the 2020 round of the Priority-driven Collaborative Cancer Research Scheme (PdCCRS).

Ten new cancer research projects totalling $2.9 million will be funded by Cancer Australia, Australian Lions Childhood Cancer Research Foundation, Cure Cancer, Leukaemia Foundation, My Room, and National Breast Cancer Foundation. The Australian Government, through Cancer Australia, will invest $2.0 million, with Funding Partners contributing a further $0.9 million to fund the successful grant applications.

Announcement of the 2020 PdCCRS Clinical Trials and Cohort Studies Grant outcomes is anticipated to occur in early June. On the day of the announcement, successful applicants will be contacted and unsuccessful applicants will be notified by email. The list of successful applicants will then be posted on the Cancer Australia website.

2021 PdCCRS Funding Round – Open

The 2021 PdCCRS grant opportunity (GO4813) is open on GrantConnect.

The closing date for submission of NHMRC Ideas grant applications WAS 5 May 2021 and all applications seeking consideration for funding through Cancer Australia’s PdCCRS must have submitted a completed application through NHMRC’s Sapphire grant management system, including submission of the detailed Ideas Grant proposal and budget, by 5 May 2021. Ideas Grant applicants indicating on the NHMRC application form that they wish to be considered for funding by Cancer Australia must also submit a PdCCRS Questions application form directly to Cancer Australia. Due to the late opening of the PdCCRS grant round, the closing date for submission of the PdCCRS Questions form to Cancer Australia will be extended to 9 June 2021, 4 weeks after the opening date of the 2021 PdCCRS round, to allow sufficient time to complete the form.

The closing date for submission of the PdCCRS Questions forms for Clinical Trials and Cohort Studies applications will be 1 September 2021, one week after the closing date of 25 August 2021 set for Clinical Trials and Cohort Studies applications by NHMRC.